The XRP price forecast is once again in the spotlight as the token holds near recent highs but shows signs of slowing momentum.The XRP price forecast is once again in the spotlight as the token holds near recent highs but shows signs of slowing momentum.

XRP Price Forecast Points To $4 By 2026 Yet This Meme Coin At $0.0053 Could Touch $0.50

2025/09/08 20:59
3 min read

The XRP price forecast is once again in the spotlight as the token holds near recent highs but shows signs of slowing momentum. XRP continues to be a cornerstone of global payments, yet many traders chasing explosive gains are shifting their focus toward presale tokens. Among these, Layer Brett ($LBRETT) is gaining strong attention, with analysts predicting it could deliver more than 50x returns in the next cycle.

XRP Price Forecast: steady but capped

XRP is trading close to $2.90. The token has held its ground after recent gains but shows signs of slowing. Support sits in the $2.75–$2.85 range, and traders are watching the $3 mark as the next big test. If it breaks higher, a move toward $3.50 could follow in the short term. Looking further ahead, most forecasts still point to $4–$5 by 2026. Ripple’s work with banks and payment firms continues to strengthen XRP’s role in cross-border settlements. 

The latest XRP price forecast reflects this shift. XRP is no longer the wild, fast-moving trade it once was. Instead, it has become a reliable hold, appealing to long-term investors who value utility and adoption. For speculators chasing 20x or 50x gains, however, XRP feels too steady compared to riskier tokens.

Why Layer Brett is gaining attention

While XRP consolidates, one of the biggest stories in September’s crypto market is the rise of Layer Brett ($LBRETT). This gem is being launched with a technical foundation on Ethereum Layer 2, bringing faster speeds, lower fees, and seamless integration with Ethereum’s decentralized applications. This mix of meme culture and infrastructure has made it stand out among new projects.

The presale price is currently $0.0055 per token, offering a low entry point with huge upside potential. A major factor behind the buzz is its staking program, which offers 865% APY for early participants. 

Beyond staking, the roadmap outlines ambitious plans including NFT tie-ins, gamified staking models, and cross-chain expansion. With a capped supply of 10 billion tokens, scarcity is built into its design, giving speculators confidence that demand could drive future price appreciation.

Momentum is also visible across social media. Telegram groups and X (formerly Twitter) feeds are filled with growing chatter about $LBRETT, with many traders comparing its rise to the early days of Shiba Inu and Pepe Coin. Analysts argue that if meme season accelerates into 2025, Layer Brett could realistically surge 50x to 100x, pushing its price from $0.0055 toward $0.50.

Final thoughts

The latest XRP price forecast points to steady growth, with short-term targets near $3.50 and longer-term projections of $4–$5 by 2026. It remains a trusted choice for investors who value stability and utility, though its gains are likely to be gradual rather than dramatic.

Layer Brett ($LBRETT), on the other hand, is capturing the speculative crowd. With its Ethereum Layer 2 base, high-yield staking, and low presale price of $0.0055, it offers the kind of setup meme traders look for when chasing outsized returns. Growing whale interest and strong community buzz suggest it could become one of the standout plays of 2025. For those willing to take on higher risk, $LBRETT may provide the explosive upside that established tokens like XRP can no longer deliver.

Presale: LayerBrett | Fast & Rewarding Layer 2 Blockchain

Telegram: Telegram: View @layerbrett

X: (1) Layer Brett (@LayerBrett) / X.

Disclaimer: This is a sponsored press release and is for informational purposes only. It does not reflect the views of Crypto Daily, nor is it intended to be used as legal, tax, investment, or financial advice.

Market Opportunity
NEAR Logo
NEAR Price(NEAR)
$0.9995
$0.9995$0.9995
-1.03%
USD
NEAR (NEAR) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Vàng Cán Mốc Lịch Sử 5.000 USD: Khi Dự Báo Của CEO Bitget Gracy Chen Trở Thành Hiện Thực Và Tầm Nhìn Về Đích Đến 5.400 USD

Vàng Cán Mốc Lịch Sử 5.000 USD: Khi Dự Báo Của CEO Bitget Gracy Chen Trở Thành Hiện Thực Và Tầm Nhìn Về Đích Đến 5.400 USD

Thị trường tài chính toàn cầu vừa chứng kiến một khoảnh khắc lịch sử chấn động: Giá Vàng thế giới [...] The post Vàng Cán Mốc Lịch Sử 5.000 USD: Khi Dự Báo Của
Share
Vneconomics2026/02/10 16:26
Why the Bitcoin Boom Is Not Another Tulip Mania

Why the Bitcoin Boom Is Not Another Tulip Mania

Bitcoin is an amazing success story. It was only invented in January of 2009 and was only worth a tiny fraction of a cent for each token. Over just a few years
Share
Medium2026/02/10 15:44
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26